Job Description
**Our position**
+ **_Division/Business Unit:_** _Medical Vaccines_
+ **_Reporting to:_** _MSL Manager, Iberia, Vaccines_
+ **_Location:_** _Ideally based in Barcelona or nearby._
+ _Up to 70% of travel expected_
**About the job**
**Our Team:**
_MSLs are the extension of the medical function in the field. They build and develop enduring ‘win-win' relationships with healthcare professionals and institutions, creating constructive partnerships with internal and external stakeholders to disseminate scientific information and generate insights. MSLs provide field or hybrid medical support that is aligned and integrated to the overall medical strategy within the BU._
_Key deliverables:_
+ _HCP/KOL engagement plans_
+ _Regional plans_
+ _Medical Metrics (entries in CRM such as insights, interactions, among others)_
_Interdependencies:_
+ Office-based medical (medical franchise heads and medica...
+ **_Division/Business Unit:_** _Medical Vaccines_
+ **_Reporting to:_** _MSL Manager, Iberia, Vaccines_
+ **_Location:_** _Ideally based in Barcelona or nearby._
+ _Up to 70% of travel expected_
**About the job**
**Our Team:**
_MSLs are the extension of the medical function in the field. They build and develop enduring ‘win-win' relationships with healthcare professionals and institutions, creating constructive partnerships with internal and external stakeholders to disseminate scientific information and generate insights. MSLs provide field or hybrid medical support that is aligned and integrated to the overall medical strategy within the BU._
_Key deliverables:_
+ _HCP/KOL engagement plans_
+ _Regional plans_
+ _Medical Metrics (entries in CRM such as insights, interactions, among others)_
_Interdependencies:_
+ Office-based medical (medical franchise heads and medica...
Ready to Apply?
Submit your application today and join our talented team at Sanofi Group.
Submit ApplicationJob Details
- Location Barcelona, Spain
- Job Type Full-time
- Category other-general
- Posted Date February 26, 2026
- Application Deadline March 06, 2026